Pharmacokinetics and safety following a single oral dose of niraparib in patients with moderate hepatic impairment.

被引：0
|
作者：
Akce, Mehmet
El-Khoueiry, Anthony B.
Piha-Paul, Sarina Anne
Bacque, Emeline
Pan, Peng
Zhang, Zhi-Yi
Ewesuedo, Reginald
Gupta, Divya
Milton, Ashley
Judson, Patricia
O'Bryant, Cindy L.
机构：
[1] Emory Univ, Winship Canc Inst, Dept Hematol & Med Oncol, Atlanta, GA 30322 USA
[2] Univ Southern Calif, Norris Comprehens Canc Ctr, Newport Beach, CA USA
[3] Univ Southern Calif, Hoag Mem Hosp, Presbyterian Canc Ctr, Newport Beach, CA USA
[4] Univ Texas MD Anderson Canc Ctr, Dept Invest Canc Therapeut, Phase Program 1, Houston, TX 77030 USA
[5] GlaxoSmithKline, Waltham, MA USA
[6] Univ Colorado, Canc Ctr, Aurora, CO USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2020年 / 38卷 / 15期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
6054
引用
收藏
页数：2
相关论文
共 50 条
  • [21] Pharmacokinetics, Safety, and Tolerability of Tanimilast Following Single Administrations in Subjects With Mild, Moderate, and Severe Hepatic Impairment
    Emirova, A.
    Piccino, A.
    Rizzo, E.
    Pittelli, M.
    Bellatti, P.
    Rostello, C.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2024, 209
  • [22] SINGLE-DOSE PHARMACOKINETICS OF ALP2011 IN SUBJECTS WITH VARIOUS DEGREES OF HEPATIC IMPAIRMENT.
    Michaud, J.
    Fazio, C.
    Boily, S.
    Massicotte, J.
    Sicard, E.
    Lefebvre, M.
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2017, 101 (S1) : S77 - S77
  • [23] Pharmacokinetics and safety of telithromycin after single and multiple doses in patients with renal impairment.
    Shi, J
    Montay, G
    Chapel, S
    Hardy, P
    Barrett, J
    Sack, M
    Marbury, T
    Swan, S
    Vargas, R
    Leclerc, V
    Leroy, B
    Bhargava, V
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2003, 73 (02) : P35 - P35
  • [24] Evaluation of the Pharmacokinetics and Safety of a Single Dose of Acalabrutinib in Subjects With Hepatic Impairment
    Xu, Yan
    Izumi, Raquel
    Nguyen, Helen
    Kwan, Anna
    Kuo, Howard
    Madere, Jeannine
    Slatter, J. Greg
    Podoll, Terry
    Vishwanathan, Karthick
    Marbury, Thomas
    Smith, William
    Preston, Richard A.
    Sharma, Shringi
    Ware, Joseph A.
    JOURNAL OF CLINICAL PHARMACOLOGY, 2022, 62 (06): : 812 - 822
  • [25] Pharmacokinetics and Safety of Single-dose Atogepant in Participants with Hepatic Impairment
    Boinpally, R.
    Jakate, A.
    Butler, M.
    Borbridge, L.
    Periclou, A.
    HEADACHE, 2020, 60 : 45 - 46
  • [26] Pharmacokinetics of Single-dose Ertugliflozin in Patients With Hepatic Impairment
    Sahasrabudhe, Vaishali
    Terra, Steven G.
    Hickman, Anne
    Saur, Didier
    Raje, Sangeeta
    Shi, Haihong
    Matschke, Kyle
    Zhou, Susan
    Cutler, David L.
    CLINICAL THERAPEUTICS, 2018, 40 (10) : 1701 - 1710
  • [27] An effect of moderate hepatic impairment on the pharmacokinetics and safety of darapladib
    Magee, Mindy He
    Shearn, Shawn
    Shaddinger, Bonnie
    Fang, Zixing
    Glaser, Ruchira
    BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2014, 78 (05) : 1014 - 1021
  • [28] EFFECT OF MODERATE HEPATIC IMPAIRMENT ON THE SAFETY AND PHARMACOKINETICS OF REZAFUNGIN
    Ong, Voon
    Sandison, Taylor
    Melara, Rebeca
    Marbury, Thomas
    Huguet, Jade
    Jandourek, Alena
    Flanagan, Shawn
    CRITICAL CARE MEDICINE, 2021, 49 (01) : 334 - 334
  • [29] PHARMACOKINETICS AND SAFETY OF SINGLE ORAL DOSES OF AMLODIPINE IN PATIENTS WITH AND WITHOUT HEPATIC IMPAIRMENT - AN OPEN STUDY
    DARNIS, F
    POUPON, R
    INTERNATIONAL JOURNAL OF CLINICAL PHARMACOLOGY RESEARCH, 1993, 13 (01) : 29 - 33
  • [30] Effects of Hepatic Impairment on Single and Multiple Oral Dose Pharmacokinetics of Voclosporin (VCS).
    Aspeslet, L.
    Freitag, D.
    Huizinga, R.
    Mayo, P.
    Ling, S.
    Foster, R.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2013, 13 : 338 - 339
12345